CHRISTOPHER B. BEGLEY - 31 Dec 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Director
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Christopher B. Begley (power of attorney previously filed)
Issuer symbol
ZBH
Transactions as of
31 Dec 2024
Transactions value $
$0
Form type
4
Filing time
03 Jan 2025, 16:08:01 UTC
Previous filing
02 Oct 2024
Next filing
02 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Phantom Stock Units Award $0 +567 +2.7% $0 21,358 31 Dec 2024 Common Stock 567 $105.73 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3 Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
F4 Includes 46.037 phantom stock units accrued on October 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.